The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models. [electronic resource]
Producer: 20150212Description: 145-57 p. digitalISSN:- 1932-7420
- Aging
- Animals
- Caenorhabditis elegans -- metabolism
- Caenorhabditis elegans Proteins -- antagonists & inhibitors
- Cells, Cultured
- Cytokines -- antagonists & inhibitors
- Disease Models, Animal
- Dopaminergic Neurons -- cytology
- Drosophila -- metabolism
- Drosophila Proteins -- antagonists & inhibitors
- Forkhead Transcription Factors -- metabolism
- Glucose -- metabolism
- Glucose-6-Phosphate Isomerase -- antagonists & inhibitors
- Glycolysis
- Insulin Receptor Substrate Proteins -- genetics
- Insulin-Like Growth Factor I -- metabolism
- Male
- Mice
- Parkinson Disease -- metabolism
- RNA Interference
- RNA, Small Interfering -- metabolism
- Receptor, Insulin -- antagonists & inhibitors
- Signal Transduction
- Transcription Factors -- antagonists & inhibitors
- alpha-Synuclein -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.